﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Preventive Epidemiology</JournalTitle>
      <Issn>2476-3934</Issn>
      <Volume>11</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>06</Month>
        <DAY>30</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Systemic inflammatory response index in IgA nephropathy; a review to recent findings</ArticleTitle>
    <FirstPage>e39273</FirstPage>
    <LastPage>e39273</LastPage>
    <ELocationID EIdType="doi">10.34172/jpe.2025.39273</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Seyed Yousef</FirstName>
        <LastName>Mojtahedi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6231-2662</Identifier>
      </Author>
      <Author>
        <FirstName>Parisa</FirstName>
        <LastName>Ashournia</LastName>
      </Author>
      <Author>
        <FirstName>Paniz</FirstName>
        <LastName>Pourpashang</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0001-2341-4965</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jpe.2025.39273</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <Abstract>Numerous studies have shown that patients with IgA nephropathy (IgAN) exhibit a range of systemic inflammatory indicators that correlate with clinical outcomes. Elevated neutrophil-to-lymphocyte ratios and systemic immune inflammation index scores have been associated with poorer renal survival and strengthened risk of progression to end-stage renal disease (ESRD). The relationship between systemic inflammation and IgAN progression provides valuable insights into potential therapeutic strategies and prognostic implications for cases suffering from this disease. However, this tool has some limitations which should be respected following its application.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Systemic inflammatory response index</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">IgA nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Biomarker</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic kidney disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">End-stage renal disease</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>